<p>Response definitions based on the top quartile of response for each method to give equal numbers of responders, n = 169.</p
a<p>All figures are counts (%) except for hospital, for which the proportion with glucose measures a...
Number of subjects classified as over the clinical cut-point for each biomarker of hyperglycemia.</p
<p>a) WBC count, b) glucose concentration, c) protein concentration. For each parameter the differen...
Defining responders to glucose lowering therapy can be important for both clinical care and for the ...
Defining responders to glucose lowering therapy can be important for both clinical care and for the ...
This is the final version of the article. Available from the publisher via the DOI in this record.AI...
<p>Proportion of responses based on most common, most effective, and least effective treatments of o...
<p>In the two example cases in the left panel, the predicted thresholds of recovery are very differe...
<p>Median (IQR) or %.</p><p>baseline characteristics of responders to GLP-1A therapy defined by HbA1...
Comparison of alpha diversity measures (Mean ± SD) in participants demonstrating improved glycemic c...
<p>Mean Diabetes Knowledge, Attitudes and Practice Scores for Different Characteristics of the Parti...
<p>(a)Response time curve for GOD-FCHIT/PT to glucose; (b) Response time curve for GOD-SCHIT/PT to g...
<p>Anthropometric and biochemical characteristics of the study population according to glucose toler...
Comparison between the glucose response to the standard insulin base therapy (orange curve) and the ...
<p>Categorical variables were expressed as numbers.</p><p>Continuous variables were expressed as mea...
a<p>All figures are counts (%) except for hospital, for which the proportion with glucose measures a...
Number of subjects classified as over the clinical cut-point for each biomarker of hyperglycemia.</p
<p>a) WBC count, b) glucose concentration, c) protein concentration. For each parameter the differen...
Defining responders to glucose lowering therapy can be important for both clinical care and for the ...
Defining responders to glucose lowering therapy can be important for both clinical care and for the ...
This is the final version of the article. Available from the publisher via the DOI in this record.AI...
<p>Proportion of responses based on most common, most effective, and least effective treatments of o...
<p>In the two example cases in the left panel, the predicted thresholds of recovery are very differe...
<p>Median (IQR) or %.</p><p>baseline characteristics of responders to GLP-1A therapy defined by HbA1...
Comparison of alpha diversity measures (Mean ± SD) in participants demonstrating improved glycemic c...
<p>Mean Diabetes Knowledge, Attitudes and Practice Scores for Different Characteristics of the Parti...
<p>(a)Response time curve for GOD-FCHIT/PT to glucose; (b) Response time curve for GOD-SCHIT/PT to g...
<p>Anthropometric and biochemical characteristics of the study population according to glucose toler...
Comparison between the glucose response to the standard insulin base therapy (orange curve) and the ...
<p>Categorical variables were expressed as numbers.</p><p>Continuous variables were expressed as mea...
a<p>All figures are counts (%) except for hospital, for which the proportion with glucose measures a...
Number of subjects classified as over the clinical cut-point for each biomarker of hyperglycemia.</p
<p>a) WBC count, b) glucose concentration, c) protein concentration. For each parameter the differen...
DOI
Add to ORKG